RDNT · RadNet, Inc. · Metrics
Market Cap
$5.85B
Shares
78.70M
RDNT metrics
83 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$75.49
Market cap
$5.85B
Price action
20 metricsPrice change (1W)
-0.5%
Price change (30D)
-3.9%
Price change (3M)
+27.6%
Price change (6M)
+24.3%
Price change (YTD)
+4.1%
Price change (1Y)
+4.2%
Trailing year
Price change (5Y)
+152.7%
52-week high
$84.48
52-week low
$51.87
Change from 52-week high
-12.1%
Change from 52-week low
+43.2%
Annualized volatility
41.9%
Annualized volatility (3M)
43.5%
Beta
1.1
RSI (14D)
54.0
Price vs SMA 50
+6.8%
Price vs SMA 200
+12.6%
Avg volume (3M)
817,540
Relative volume
1.0
Average dollar volume
$54.00M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
78.70M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.8×
reciprocal yield 35.2%
EV / EBITDA
26.7×
reciprocal yield 3.7%
EV / EBIT
91.2×
reciprocal yield 1.1%
P / sales
2.6×
reciprocal yield 38.8%
P / book
5.3
reciprocal yield 18.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
18.9
reciprocal yield 5.3%
Earnings yield
-0.4%
Historical valuation
8 metricsP / E historical average (3Y)
327.5×
reciprocal yield 0.3%
P / E historical average (5Y)
264.3×
reciprocal yield 0.4%
EV / revenue historical average (3Y)
2.6×
reciprocal yield 38.0%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 46.2%
EV / EBIT historical average (3Y)
64.4×
reciprocal yield 1.6%
EV / EBIT historical average (5Y)
53.2×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
22.0×
reciprocal yield 4.5%
EV / EBITDA historical average (5Y)
18.0×
reciprocal yield 5.6%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-10
Profitability
9 metricsGross margin
—
Operating margin
3.1%
Trailing 12 months
Net margin
-0.9%
Gross profit (TTM)
—
Operating profit (TTM)
$70.78M
Net income (TTM)
−$21.12M
Trailing 12 months
Diluted EPS (TTM)
$-0.26
FCF margin
—
Effective tax rate
44.9%
Growth
11 metricsRevenue growth YoY
+25.0%
Year over year
Net income growth YoY
-47.9%
Revenue (TTM)
$2.27B
Trailing 12 months
EPS growth YoY
-47.4%
Shares change YoY
+4.2%
Year over year · more shares
Revenue CAGR (3Y)
+12.6%
Revenue CAGR (5Y)
+13.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-2.3%
FCF CAGR (5Y)
+18.3%
Quality
14 metricsReturn on equity
-1.9%
Return on assets
-0.5%
Debt / equity
1.2
Current ratio
1.5
EBITDA (TTM)
$241.93M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
2.5
Return on invested capital
2.3%
Trailing 12 months
Net cash
−$606.26M
Latest balance sheet
Cash & equivalents
$726.27M
Total assets
$4.23B
Total debt
$1.33B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$310.06M
Capital expenditures (TTM)
$74.15M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$59.28M
R&D / revenue
—
Stock compensation / revenue
2.6%
Ownership (13F)
3 metrics13F filers
331
13F filer change QoQ
-13
Institutional ownership
103.5%
Short interest
3 metricsShort interest
12.6%
Latest settlement · 19.5 days to cover
Days to cover
19.5d
Short-squeeze score
85 / 100
Insider activity
2 metricsNet insider buying (90D)
−$2.98M
Insider-sentiment score
20 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
790526
CUSIP
750491102
13F (30d)
125 filings
125 filers
Visit website
Investor relations